As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...

A prostate cancer diagnosis rarely comes with one obvious answer. It comes with several reasonable paths that differ in side effects, recovery and long term tradeoffs, and the right one depends on the ...

Prostate cancer is the most commonly diagnosed cancer in American men — and the second leading cause of cancer-related deaths. One in eight men will be diagnosed in their lifetime. And Black men are ...

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...

Men newly diagnosed with prostate cancer face a range of treatment options, from robotic surgery and focal therapy to ...

In an interview, Dr. David A. Taub highlighted Prostate Cancer Awareness Month by outlining current treatment options for patients with prostate cancer. In an interview with CURE, Dr. David A. Taub ...

VIR-5500 and [²¹²Pb]PSV359 received FDA fast track designations for prostate cancer and solitary fibrous tumors, respectively ...

Vir Biotechnology’s T-cell engager ‘VIR-5500’ gets US FDA’s fast track designation to treat prostate cancer: San Francisco Saturday, October 10, 2026, 15:00 Hrs [IST] Vir ...

Hormone blockade therapy, which includes both oral and injectable options, aims to slow or stop the growth of prostate cancer cells by reducing androgen levels. Injectable hormone blockade therapies, ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

"The number of men living with prostate cancer also continues to rise, so it's vital that we see investment in prostate ...

The American Cancer Society predicts 1 in 8 men will be diagnosed with prostate cancer in their lifetime.